Cara Therapeutics Quote - 0HTC

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

140.40

Bid

0.00

Ask

0.00

Volume

160

0.00 Day's Range 0.00

140.40 52 Week Range 140.40

Market Cap

7.649B

Previous Close

140.40

Open

Last Trade

160

4.3685

(O)

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

4,949

Shares Outstanding

54,481,000

Dividend Yield

PE Ratio

-2.14

Earnings Per Share (EPS)

-2.18

Revenue

20.97M

Net Profit

-118.51M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.caratherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

Cara Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0HTC. The last closing price for Cara Therapeutics was US$140.40. Over the last year, Cara Therapeutics shares have traded in a share price range of US$ 140.40 to US$ 140.40.

Cara Therapeutics currently has 54,481,000 shares outstanding. The market capitalization of Cara Therapeutics is US$7.65 billion. Cara Therapeutics has a price to earnings ratio (PE ratio) of -2.14.

No news to show yet.

Period	Open	High	Low	Avg. Daily Vol	VWAP
1	140.4	140.4	140.4	277	140.4	DE
4	140.4	140.4	140.4	115	140.4	DE
12	140.4	140.4	140.4	4949	140.4	DE
26	140.4	140.4	140.4	6096	140.4	DE
52	140.4	140.4	140.4	6952	140.4	DE
156	140.4	140.4	140.4	3909	140.4	DE
260	140.4	140.4	140.4	2458	140.4	DE

0HTC - Frequently Asked Questions (FAQ)

What is the current Cara Therapeutics share price?

The current share price of Cara Therapeutics is US$ 140.40

How many Cara Therapeutics shares are in issue?

Cara Therapeutics has 54,481,000 shares in issue

What is the market cap of Cara Therapeutics?

The market capitalisation of Cara Therapeutics is USD 7.65B

What is the 1 year trading range for Cara Therapeutics share price?

Cara Therapeutics has traded in the range of US$ 140.40 to US$ 140.40 during the past year

What is the PE ratio of Cara Therapeutics?

The price to earnings ratio of Cara Therapeutics is -2.14

What is the cash to sales ratio of Cara Therapeutics?

The cash to sales ratio of Cara Therapeutics is 12.11

What is the reporting currency for Cara Therapeutics?

Cara Therapeutics reports financial results in USD

What is the latest annual turnover for Cara Therapeutics?

The latest annual turnover of Cara Therapeutics is USD 20.97M

What is the latest annual profit for Cara Therapeutics?

The latest annual profit of Cara Therapeutics is USD -118.51M

What is the registered address of Cara Therapeutics?

The registered address for Cara Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Cara Therapeutics website address?

The website address for Cara Therapeutics is www.caratherapeutics.com

Which industry sector does Cara Therapeutics operate in?

Cara Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TUNTungsten West Plc	5.25p (55.56%)	5.82M
SIVSivota Plc	4.50p (50.00%)	10k
MATDPetro Matad Limited	2.225p (48.33%)	39.09M
MET1Metals One Plc	0.725p (26.09%)	10.06M
SAVESavannah Energy Plc	11.90p (19.60%)	12.27M
PR1Pri0r1ty Intelligence Group Plc	4.00p (-27.27%)	420k
NTQEnteq Technologies Plc	1.70p (-17.07%)	1.03M
FCMFirst Class Metals Plc	1.55p (-16.22%)	1.94M
BVCBatm Advanced Communications Ld	14.55p (-15.65%)	1.27M
AFRNAferian Plc	3.00p (-14.29%)	69.34k
VELAVela Technologies Plc	0.0027p (-6.90%)	501.87M
MSMNMosman Oil And Gas Limited	0.034p (13.33%)	432.08M
PREMPremier African Minerals Limited	0.021p (7.69%)	301.55M
LLOYLloyds Banking Group Plc	73.24p (2.55%)	295.3M
VRSVersarien Plc	0.028p (-12.50%)	256.45M